Viebahn C, Birgitte Lane E, Ramaekers F
Rouxs Arch Dev Biol. 2017; 201(1):45-60.
PMID: 28305611
DOI: 10.1007/BF00188775.
Serrano Fernadez M, Alvarez Merino J, Martinez Zubiaurre I, Fernandez Garcia A, Sanchez Rovira P, Lorente Acosta J
Clin Transl Oncol. 2009; 11(10):659-68.
PMID: 19828408
DOI: 10.1007/s12094-009-0421-z.
Carr T, Adair S, Fink M, Hogan K
Cancer Immunol Immunother. 2007; 57(1):31-42.
PMID: 17579858
PMC: 11031052.
DOI: 10.1007/s00262-007-0347-7.
Brotherick I, Browell D, Shenton B, Egan M, Cunliffe W, Webb L
Br J Cancer. 1998; 77(10):1657-60.
PMID: 9635844
PMC: 2150047.
DOI: 10.1038/bjc.1998.272.
Wheeler J, Robertson H, Watchorn C, Morley A
Histochem J. 1993; 25(3):219-27.
PMID: 8473201
DOI: 10.1007/BF00163818.
Patterns of cytokeratin expression by neoplastic and non-neoplastic epithelium.
Mortimer G, Jones D, Assaf H
Ir J Med Sci. 1993; 162(3):77-81.
PMID: 7682540
DOI: 10.1007/BF02942094.
Changes in cytokeratin expression in epidermal keratinocytes during wound healing.
Watanabe S, Osumi M, Ohnishi T, Ichikawa E, Takahashi H
Histochem Cell Biol. 1995; 103(6):425-33.
PMID: 7584549
DOI: 10.1007/BF01457542.
p53 expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer.
Brotherick I, Shenton B, Cowan W, Angus B, Horne C, Higgs M
Cancer Immunol Immunother. 1995; 41(3):146-50.
PMID: 7553682
PMC: 11037752.
DOI: 10.1007/BF01521339.
The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer.
Brotherick I, Shenton B, Cowan W, Angus B, Horne C, Higgs M
Cancer Immunol Immunother. 1995; 41(3):137-45.
PMID: 7553681
PMC: 11037769.
DOI: 10.1007/BF01521338.
Are fine-needle breast aspirates representative of the underlying solid tumour? A comparison of receptor levels, ploidy and the influence of cytokeratin gates.
Brotherick I, Shenton B, Lennard T
Br J Cancer. 1995; 72(3):732-7.
PMID: 7545418
PMC: 2033883.
DOI: 10.1038/bjc.1995.402.
Cytokeratin expression in non-neoplastic oesophageal epithelium and squamous cell carcinoma of the oesophagus.
Lam K, Loke S, Shen X, Ma L
Virchows Arch. 1995; 426(4):345-9.
PMID: 7541275
DOI: 10.1007/BF00191342.
R-body-producing bacteria.
Pond F, Gibson I, Lalucat J, Quackenbush R
Microbiol Rev. 1989; 53(1):25-67.
PMID: 2651865
PMC: 372716.
DOI: 10.1128/mr.53.1.25-67.1989.
Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study.
Randall B, Angus B, Akiba R, Hall A, Cattan A, Proctor S
Br J Cancer. 1990; 62(4):614-8.
PMID: 2223578
PMC: 1971495.
DOI: 10.1038/bjc.1990.340.
UNME/K1: an IgG2a monoclonal antibody specific to cytokeratin of human urinary bladder squamous cell carcinoma.
El-Mohamady H, Basta M, Seddek M, Helmy H, Attallah A, Ghoneim M
Urol Res. 1991; 19(2):145-50.
PMID: 1712997
DOI: 10.1007/BF00368194.
Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study.
Doglioni C, DellOrto P, Zanetti G, Iuzzolino P, Coggi G, Viale G
Virchows Arch A Pathol Anat Histopathol. 1990; 416(6):479-90.
PMID: 1692434
DOI: 10.1007/BF01600298.
Cytokeratin expression and early lens development.
Kasper M, Viebahn C
Anat Embryol (Berl). 1992; 186(3):285-90.
PMID: 1384393
DOI: 10.1007/BF00174151.